DDRiver
Showing 1 - 6 of 6
NSCLC Trial in Pittsburgh (M1774, Cemiplimab)
Not yet recruiting
- Non-Small Cell Lung Cancer
-
Pittsburgh, PennsylvaniaUPMC Cancer Center
May 22, 2023
Metastatic or Locally Advanced Unresectable Solid Tumors Trial in Canada, Spain, United States (M1774, Drug A (DNA Damage
Recruiting
- Metastatic or Locally Advanced Unresectable Solid Tumors
- M1774
- +2 more
-
Houston, Texas
- +4 more
Jul 7, 2022
Small-cell Lung Cancer Trial in Worldwide (Berzosertib, Topotecan)
Active, not recruiting
- Small-cell Lung Cancer
-
Santa Rosa, California
- +47 more
Jun 24, 2022
Locally Advanced Rectal Cancer Trial in Spain, United States (Peposertib 50 mg, Peposertib 100 mg, Peposertib 150 mg)
Completed
- Locally Advanced Rectal Cancer
- Peposertib 50 mg
- +5 more
-
Aurora, Colorado
- +13 more
Jun 9, 2022